Do you want to read an article? Please log in or register.
Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity
Asthma
RECOMMENDED
Related content
COMMENTED
Duration of the efficacy of omalizumab after treatment discontinuation in 'real life' severe asthma
Thorax.
Vennera MDC, Sabadell C, Picado C; Spanish Omalizumab Registry
doi: 10.1136/thoraxjnl-2017-
Asthma
Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study
J Asthma.
Albers FC, Müllerová H, Gunsoy NB, Shin JY, Nelsen LM, Bradford ES, Cockle SM, Suruki RY
doi: 10.1080/02770903.
RECOMMENDED
Asthma
Does allergy explain why some children have severe asthma?
Clin Exp Allergy.
Bonner K, Roberts G
doi: 10.1111/cea.13234.
Asthma
Appropriate selection for omalizumab treatment in patients with severe asthma?
Eur Clin Respir J.
Nygaard L, Henriksen DP, Madsen H, Davidsen JR
doi: 10.1080/20018525.
Asthma
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience
J Allergy Clin Immunol.
Chipps BE, Lanier B, Milgrom H, Deschildre A, Hedlin G, Szefler SJ, Kattan M7, Kianifard F, Ortiz B, Haselkorn T, Iqbal A, Rosén K, Trzaskoma B, Busse WW
doi: 10.1016/j.jaci.2017.03.002.
Asthma
Biologics in the treatment of severe asthma
Allergol Immunopathol (Madr).
Quirce S, Phillips-Angles E, Domínguez-Ortega J, Barranco P
doi: 10.1016/
RECOMMENDED
Asthma
Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison
J Allergy Clin Immunol.
Busse W, Chupp G, Nagase H, Albers FC, Doyle S, Shen Q, Bratton DJ, Gunsoy NB
doi: 10.1016/j.jaci.2018.08.031.
RECOMMENDED
Asthma
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy
Tognella S, Micheletto C, Roggeri A, Polese G, Artioli D, Senna G, Caminati M, Roggeri DP
doi: 10.2147/JAA.S309740
AsthmaCOPD
Omalizumab Treatment Response in a Severe Allergic Asthma Population with Overlapping COPD
Chest.
Maltby S, Gibson PG, Powell H, McDonald VM
doi: 10.1016/